文献速递神经免疫

脑脊液髓鞘少突胶质细胞糖蛋白抗体的意义:一项回顾性多中心研究

Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study.
PubMed 文献 · Neurology · 2022-12-16

这项回顾性多中心研究纳入11个医学中心255例疑似中枢神经系统炎性疾病且血清和/或脑脊液MOG抗体阳性的成人和儿童患者,发现血清和脑脊液双阳性常见且与更严重临床表现相关,仅脑脊液阳性可发生于表型提示MOGAD的患者并与更差结局相关。

要点

  • 血清和脑脊液MOG抗体双阳性患者发作期EDSS中位数4.5,高于单血清阳性者的3.0。
  • 仅脑脊液MOG抗体阳性多见于成人(成人22% vs 儿童3%),且与末次随访更高残疾相关。
  • 仅脑脊液MOG抗体阳性状态与EDSS≥3.0独立相关。

核心结论

  • 血清和脑脊液配对MOG抗体阳性在MOGAD中常见,并与更严重的临床表现相关。
  • 仅脑脊液MOG抗体阳性可发生于表型提示MOGAD的患者,并与更差结局相关。
  • 这些数据提示对表型提示MOGAD的患者评估脑脊液MOG抗体具有临床意义,无论血清MOG抗体状态如何。

研究设计与样本

  • 11个医学中心回顾性收集成人和儿童疑似中枢神经系统炎性疾病且血清和/或脑脊液MOG抗体阳性的临床和实验室数据,采用活细胞法检测。
  • 队列共255例患者,其中女性139例(55%),儿童(即<18岁)132例(52%)。
  • 比较采用参数或非参数检验,不良结局的潜在因素采用Cox比例风险模型和logistic回归探索。

主要发现

  • 145例(56.8%)血清和脑脊液均MOG抗体阳性,79例(31%)仅血清阳性,31例(12%)仅脑脊液阳性。
  • 仅脑脊液阳性者中成人占22%、儿童占3%,更常表现为运动症状(n=14,45%)和感觉症状(n=13,42%),除4例外最终诊断符合MOGAD(2例多发性硬化、1例多神经根神经炎、1例Susac综合征)。
  • 血清阳性患者中,脑脊液阳性者发作期EDSS中位数4.5(IQR 3.0-7.5) vs 脑脊液阴性者3.0(IQR 2.0-6.8),p=0.007。
  • 血清阳性且脑脊液阳性者较脑脊液阴性者更常见感觉症状(45.5% vs 24%,p=0.002)、运动症状(33.6% vs 19%,p=0.021)和括约肌症状(26.9% vs 7.8%,p=0.001)。
  • 末次随访时血清阳性且脑脊液阳性者更常有持续性括约肌功能障碍(17.3% vs 4.3%,p=0.008)。

临床怎么用

  • 原文结论提示对表型提示MOGAD的患者评估脑脊液MOG抗体具有临床意义,无论血清MOG抗体状态如何。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Although the diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is based on serum MOG antibodies (MOG-Abs) positivity, patients with coexisting or restricted MOG-Abs in the CSF have been reported. The aim of this study is to characterize the relevance of CSF MOG-Abs positivity in clinical practice. METHODS: Eleven medical centers retrospectively collected clinical and laboratory data of adult and pediatric patients with suspected inflammatory CNS disease and MOG-Abs positivity in serum and/or CSF using live cell-based assays. Comparisons were performed using parametric or nonparametric tests, as appropriate. Potential factors of unfavorable outcomes were explored by Cox proportional hazard models and logistic regression. RESULTS: The cohort included 255 patients: 139 (55%) women and 132 (52%) children (i.e., <18-year-old). Among them, 145 patients (56.8%) had MOG-Abs in both serum and CSF (MOG-Abs seropositive and CSF positive), 79 (31%) only in serum (MOG-Abs seropositive and CSF negative), and 31 (12%) only in CSF (MOG-Abs seronegative and CSF positive). MOG-Abs seronegative and CSF positive predominated in adults (22% vs 3% of children), presented more commonly with motor (n = 14, 45%) and sensory symptoms (n = 13, 42%), and all but 4 (2 multiple sclerosis, 1 polyradiculoneuritis, and 1 Susac syndrome) had a final diagnosis compatible with MOGAD. When comparing seropositive patients according to MOG-Abs CSF status, MOG-Abs seropositive and CSF positive patients had a higher Expanded Disability Status Scale (EDSS) at nadir during the index event (median 4.5, interquartile range [IQR] 3.0-7.5 vs 3.0, IQR 2.0-6.8, p = 0.007) and presented more commonly with sensory (45.5% vs 24%, p = 0.002), motor (33.6% vs 19%, p = 0.021), and sphincter symptoms (26.9% vs 7.8%, p = 0.001) than MOG-Abs seropositive and CSF negative. At the last follow-up, MOG-Abs seropositive and CSF positive cases had more often persistent sphincter dysfunction (17.3% vs 4.3%, p = 0.008). Compared with seropositive patients, those MOG-Abs seronegative and CSF positive had higher disability at the last follow-up (p ≤ 0.001), and MOG-Abs seronegative and CSF positive status were independently associated with an EDSS ≥3.0. DISCUSSION: Paired serum and CSF MOG-Abs positivity are common in MOGAD and are associated with a more severe clinical presentation. CSF-only MOG-Abs positivity can occur in patients with a phenotype suggestive of MOGAD and is associated with a worse outcome. Taken together, these data suggest a clinical interest in assessing CSF MOG-Abs in patients with a phenotype suggestive of MOGAD, regardless of the MOG-Abs serostatus.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Carta S, Cobo Calvo Á, Armangué T, et al. Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study. Neurology. 2022. PMID: 36526426. doi:10.1212/WNL.0000000000201662

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。